Results 171 to 180 of about 17,989 (193)

ANCA associated pulmonary fibrosis: vasculitis or not vasculitis

Current Opinion in Pulmonary Medicine
Purpose of review The intersection of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and interstitial lung disease (ILD) represents a complex and increasingly recognized clinical challenge. This review aims to summarize current understanding, highlight diagnostic and therapeutic approaches, and identify ...
Codes-Méndez, H, Castillo, D, Moya-Alvarado, P, Giménez-Palleiro, A, Castellvi, I   +4 more
openaire   +3 more sources

Spectrum of ANCA-Associated Vasculitis

The Indian Journal of Pediatrics, 2017
Aditi, Sinha, Arvind, Bagga
openaire   +2 more sources

Immunosuppression in ANCA-associated vasculitis

Transplantation Proceedings, 2001
F J, van der Woude, W H, Schmitt, R, Birck, R, Nowack, U, Göbel, J M, Drexler, O, Hotta   +6 more
openaire   +2 more sources

The involvement of NETs in ANCA-associated vasculitis

Frontiers in Immunology, 2023
Daigo Nakazawa, Nakazawa Daigo
exaly  

The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis

Autoimmunity Reviews, 2021
Marco Wj Schreurs, Paul L A Van Daele
exaly  

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

New England Journal of Medicine, 2020
Oliver Floßmann, , Loïc Guillevin
exaly  

Clinical associations of renal involvement in ANCA-associated vasculitis

Autoimmunity Reviews, 2020
Luis F Quintana, Peter Merkel, Keum Hwa Lee   +2 more
exaly  

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

New England Journal of Medicine, 2010
, Duvuru Geetha, Peter Merkel
exaly  

Genetically Distinct Subsets within ANCA-Associated Vasculitis

New England Journal of Medicine, 2012
Mark A Little, Loïc Guillevin
exaly  

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

New England Journal of Medicine, 2010
Vladimir Tesar, , Michael Walsh
exaly